DRUG SPOTLIGHT Cytisinicline
Cytisinicline is an emerging smoking cessation therapy that has demonstrated strong quit rates and favorable tolerability in clinical trials, positioning it as a promising new option for individuals looking to overcome nicotine dependence.
Go to: DRUG SPOTLIGHT Cytisinicline
A New Look, The Same Trusted Commitment
What began as a mission-driven alternative to traditional PBMs has grown into a trusted partner for organizations across the country. As ClearScript has evolved, so has our vision for the…
Go to: A New Look, The Same Trusted Commitment
How PBMs Help Manage Stop Loss Risk: What Brokers and Employers Need to Know
Rising stop loss premiums are putting new pressure on self funded employers and the brokers who advise them. Many plans are seeing increased renewal rates, driven in part by specialty…
Go to: How PBMs Help Manage Stop Loss Risk: What Brokers and Employers Need to Know
